Published in Ophthalmology on June 01, 1989
Localization of a novel X-linked progressive cone dystrophy gene to Xq27: evidence for genetic heterogeneity. Am J Hum Genet (1997) 1.68
What young people think and do when the option for cystic fibrosis carrier testing is available. J Med Genet (1993) 1.68
X-linked cone-rod dystrophy (locus COD1): identification of mutations in RPGR exon ORF15. Am J Hum Genet (2002) 1.62
Identification and functional consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant cone dystrophy. Am J Hum Genet (2001) 1.23
Cone and cone-rod dystrophies. J Med Genet (1992) 1.13
Clinical diversity and chromosomal localization of X-linked cone dystrophy (COD1). Am J Hum Genet (1994) 1.07
X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene. J Med Genet (2006) 1.05
X linked progressive cone dystrophy. Localisation of the gene locus to Xp21-p11.1 by linkage analysis. Br J Ophthalmol (1994) 1.03
Genetic mapping of a cone and rod dysfunction (Aland Island eye disease) to the proximal short arm of the human X chromosome. J Med Genet (1993) 0.95
Linkage analysis of X-linked cone-rod dystrophy: localization to Xp11.4 and definition of a locus distinct from RP2 and RP3. Am J Hum Genet (1998) 0.92
A new genetic locus for X linked progressive cone-rod dystrophy. J Med Genet (2003) 0.89
X linked progressive cone dystrophy with specific attention to carrier detection. J Med Genet (1992) 0.87
ERGs, cone-isolating VEPs and analytical techniques in children with cone dysfunction syndromes. Doc Ophthalmol (2003) 0.81
Pingelapese achromatopsia: correlation between paradoxical pupillary response and clinical features. Br J Ophthalmol (2004) 0.76
Psychosocial genetics: an emerging scientific discipline. J Med Genet (1993) 0.75
Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol (1982) 3.50
Adrenergic mydriasis in Horner's syndrome. Hydroxyamphetamine test for diagnosis of postganglionic defects. Am J Ophthalmol (1971) 2.04
Adie's syndrome: some new observations. Trans Am Ophthalmol Soc (1977) 1.81
Deletions of different segments of the long arm of chromosome 4. Am J Med Genet (1981) 1.72
Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr (1983) 1.68
Critical evaluation of the cocaine test in the diagnosis of Horner's syndrome. Arch Ophthalmol (1990) 1.63
The tonic pupil: a re-evaluation. Am J Ophthalmol (1967) 1.62
Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr (2000) 1.60
Fuchs's heterochromic cyclitis: A critical review of the literature. I. Clinical characteristics of the syndrome. Surv Ophthalmol (1974) 1.57
Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol (1986) 1.49
Downbeat nystagmus associated with dolichoectasia of the vertebrobasilar artery. Arch Neurol (1989) 1.44
Congenital Horner's syndrome. Arch Ophthalmol (1980) 1.43
The diagnosis and prognosis of atypical carotid-cavernous fistula (red-eyed shunt syndrome). Am J Ophthalmol (1982) 1.41
Pupillary signs in the diagnosis of optic nerve disease. Trans Ophthalmol Soc U K (1976) 1.40
Hydroxyamphetamine mydriasis in Horner's syndrome. Am J Ophthalmol (1990) 1.39
An anisocoria produces a small relative afferent pupillary defect in the eye with the smaller pupil. J Neuroophthalmol (1999) 1.38
The binding of deoxyribonucleic acid and histone in native nucleohistone. J Biol Chem (1972) 1.37
How to measure the relative afferent pupillary defect. Surv Ophthalmol (1981) 1.35
Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis (1996) 1.33
The relationship between visual acuity, pupillary defect, and visual field loss. Am J Ophthalmol (1982) 1.32
Pupillary "dilatation lag" in Horner's syndrome. Br J Ophthalmol (1975) 1.29
Raeder's syndrome. A clinical review. Surv Ophthalmol (1980) 1.29
Edge-light pupil cycle time. Br J Ophthalmol (1978) 1.25
Afferent pupillary defects. Pupillary findings associated with defects of the afferent arm of the pupillary light reflex arc. Am J Ophthalmol (1966) 1.24
Linkage localization of Börjeson-Forssman-Lehmann syndrome. Am J Med Genet (1989) 1.23
The effect of target behavior monitoring on weight loss and completion rate in a behavior modification program for weight reduction. Addict Behav (1986) 1.22
The rational management of idiopathic intracranial hypertension. Arch Neurol (1989) 1.17
Holmes-Adie syndrome with segmental hypohidrosis. Neurology (1967) 1.17
Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal insufficiency associated with Xp21 interstitial deletion. J Pediatr (1986) 1.11
Mental retardation and multiple congenital anomalies of unknown etiology: frequency of occurrence in similarly affected sibs of the proband. Birth Defects Orig Artic Ser (1978) 1.11
Automated pupil perimetry. Pupil field mapping in patients and normal subjects. Ophthalmology (1991) 1.10
Psychosocial mediators of racial differences in nighttime blood pressure dipping among normotensive adults. Health Psychol (1999) 1.09
Diagnosing Horner's syndrome. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1978) 1.09
Functional visual loss. Follow-up of 42 cases. Arch Ophthalmol (1983) 1.07
Hydroxyamphetamine mydriasis in normal subjects. Am J Ophthalmol (1990) 1.05
Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology (1993) 1.05
The viscosity of nucleohistone in urea. Biochim Biophys Acta (1968) 1.04
Cholinergic supersensitivity of the iris sphincter in Adie's tonic pupil. Am J Ophthalmol (1978) 1.04
Relative afferent pupillary defect in central retinal vein occlusion. Ophthalmology (1986) 1.04
The relationship between static perimetry and the relative afferent pupillary defect. Am J Ophthalmol (1993) 1.03
Pupillary defects in amblyopia. Am J Ophthalmol (1983) 1.00
Enlargement of the blind spot caused by papilledema. Am J Ophthalmol (1988) 1.00
Oculomotor paresis with cyclic spasms. A critical review of the literature and a new case. Surv Ophthalmol (1976) 0.99
Recurrent lateral rectus palsy in childhood. Pediatr Neurol (1991) 0.97
Interstitial deletion of the short arm of chromosome 17. Hum Genet (1984) 0.97
Relative afferent pupillary defect in optic tract hemianopias. Am J Ophthalmol (1978) 0.96
Functional visual loss. Am J Ophthalmol (1985) 0.95
Localisation of Xp21 meiotic exchange points in Duchenne muscular dystrophy families. J Med Genet (1986) 0.95
Tadpole-shaped pupils caused by segmental spasm of the iris dilator muscle. Am J Ophthalmol (1983) 0.95
Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City. Public Health Genomics (2011) 0.94
Late-onset oculogastrointestinal muscular dystrophy. Am J Med Genet (1984) 0.94
Microcephaly in familial holoprosencephaly. J Craniofac Genet Dev Biol (1988) 0.93
Gene dosage effect for glycinamide ribonucleotide synthetase in human fibroblasts trisomic for chromosome 21. Biochem Biophys Res Commun (1980) 0.93
The prevalence of simple anisocoria. Am J Ophthalmol (1987) 0.92
Mydriasis and increased intraocular pressure. I. Pupillographic studies. Arch Ophthalmol (1972) 0.92
Visual evoked potential and pupillary signs. A comparison in optic nerve disease. Arch Ophthalmol (1982) 0.91
Corneal sensation in Adie's syndrome. Am J Ophthalmol (1977) 0.91
Pupil cycle time in optic neuritis. Am J Ophthalmol (1978) 0.91
Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagen. Agents Actions (1986) 0.90
Visual function abnormalities in central serous retinopathy. Arch Ophthalmol (1984) 0.89
Functional visual loss: II. Psychiatric aspects in 42 patients followed for 4 years. Psychol Med (1983) 0.89
Bilateral microphthalmos with orbital cysts: MR findings. J Comput Assist Tomogr (1987) 0.89
Segmental palsy of the iris sphincter in Adie's syndrome. Arch Ophthalmol (1978) 0.88
Cis-dichlorodiammineplatinum [II]: inhibition of nucleic acid synthesis in lymphocytes stimulated with phytohemagglutinin. Proc Soc Exp Biol Med (1971) 0.88
Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol (1989) 0.88
Relative afferent pupillary defects in optic neuritis. Am J Ophthalmol (1981) 0.88
Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts. J Infect Dis (1999) 0.88
Drugs and sport. Research findings and limitations. Sports Med (1997) 0.88
Is applanation tonometry a risk factor for transmission of Creutzfeldt-Jakob disease? Arch Ophthalmol (1987) 0.88
The analysis of anisocoria. The use of photography in the clinical evaluation of unequal pupils. Can J Ophthalmol (1979) 0.88
Amaurosis fugax: the results of arteriography in 59 patients. Stroke (1984) 0.88
Hydroxyamphetamine. A good drug lost? Am J Ophthalmol (1991) 0.87
Differentiation between recently resolved optic neuritis and central serous retinopathy. Use of tests of visual function. Arch Ophthalmol (1985) 0.87
Use of infrared videography to detect and record iris transillumination defects. Arch Ophthalmol (1990) 0.87
Upbeat nystagmus changing to downbeat nystagmus with convergence. Neurology (1981) 0.87
Tables of diagnostic pupillary drug tests. Bristol Med Chir J (1975) 0.86
Relative afferent pupillary defect in eyes with retinal detachment. Ophthalmic Surg (1987) 0.85
Hippus. Semantic and historic considerations of the word. Am J Ophthalmol (1971) 0.85
Impaired critical flicker frequency in recovered optic neuritis. Ann Neurol (1991) 0.85
Low affinity antibodies against collagen type II are associated with pathology in collagen-induced arthritis in mice. J Autoimmun (1990) 0.85
Ischaemic ocular necrosis from carotid-cavernous fistula. Pathology of stagnant anoxic "inflammation" in orbital and ocular tissues. Br J Ophthalmol (1973) 0.85
A unilateral cataract produces a relative afferent pupillary defect in the contralateral eye. Ophthalmology (1990) 0.85
Hippus. Arch Intern Med (1969) 0.85
Decreased visual acuity from optic disc drusen. Arch Ophthalmol (1985) 0.85
Selective MR imaging approach for evaluation of patients with Horner's syndrome. AJNR Am J Neuroradiol (1992) 0.85
Downbeating nystagmus and other ocular motor defects caused by lithium toxicity. Neurology (1989) 0.84
Pupillary responses to dilute pilocarpine in preganglionic 3rd nerve disorders. Neurology (1990) 0.84
Functional visual loss: I. A true psychiatric disorder? Psychol Med (1983) 0.84
Effect of light on the prevalence of simple anisocoria. Ophthalmology (1996) 0.83
The multiple evanescent white-dot syndrome with acute blind spot enlargement. Am J Ophthalmol (1989) 0.83
Concordance of X-linked glycerol kinase deficiency with X-linked congenital adrenal hypoplasia. Lancet (1982) 0.83
Diagnosis of the empty sella with intrathecal metrizamide computed tomography. Surv Ophthalmol (1983) 0.82
Pseudotumor cerebri syndrome associated with Lyme disease. Am J Ophthalmol (1989) 0.82
Mydriasis and increased intraocular pressure. II. Iris fluorescein studies. Arch Ophthalmol (1972) 0.81
Arthritis: animal models of oral tolerance. Ann N Y Acad Sci (1996) 0.81
Analysis of speech characteristics in children with velocardiofacial syndrome (VCFS) and children with phenotypic overlap without VCFS. Cleft Palate Craniofac J (2001) 0.81
X-linked congenital stationary night blindness with myopia and nystagmus without clinical complaints of nyctalopia. J Pediatr Ophthalmol Strabismus (1988) 0.80
Pseudo-Horner's syndrome. Arch Neurol (1982) 0.80
Difficulty differentiating Leber's from dominant optic neuropathy in a patient with remote visual loss. J Clin Neuroophthalmol (1991) 0.80
Ciliary muscle dysfunction in Adie's syndrome. Arch Ophthalmol (1978) 0.80